Wegovy ® (semaglutide) is an injectable weight loss drug for people with an initial BMI of 30 kg/m² or higher (classed as obese). It is also appropriate for people with a BMI between 27 kg/m² and 30 kg/m² (classed as overweight) if you also have weight-related health issues such as prediabetes, high blood pressure, sleep apnea, high cholesterol, or heart problems.
For individuals from Asian, Black African, African-Caribbean, or Middle Eastern backgrounds, the thresholds for overweight and obese categories are reduced by 2.5 kg/m² to reflect their higher risk at lower BMIs.